Dáil Éireann Debate, Wednesday - 6 May 2026
897. Deputy Colm Burke asked the Minister for Health if she will provide details of the HPRA’s engagement with patient groups and stakeholders during its ongoing review of over-the-counter codeine medicines which commenced in November 2022, including which organisations were consulted and the nature of that engagement; and if she will make a statement on the matter. [32235/26]
View answerThe Health Products Regulatory Authority (HPRA) is the competent authority for medicines in Ireland and is currently conducting an independent review of the method of sale and supply of codeine-containing medicinal products that are currently available without a medical prescription in Ireland. It is expected that the HPRA will finalise this review in 2026.
As the HPRA classification review into medicinal products containing low dose codeine available over the counter in Ireland is ongoing, it is not appropriate to comment on any related stakeholder engagement at present.
